Brief: Index Pharmaceuticals Evaluates Strategic Alternatives

Flerie AB

21/02/2024 07:15

Feb 21 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * WE HAVE BEEN EVALUATING POSSIBLE PATHS FORWARD FOR INDEX
    * VARIOUS ALTERNATIVES ARE BEING CONSIDERED, FOR EXAMPLE
LIQUIDATION, REVERSE MERGER, AND PUBLIC BIDS

Source text for Eikon:  ID:nWkrc9CGzM 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))